{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-045109","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.073944+00:00","generated_at":"2026-05-21T02:06:11.651862+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Envoy Medical CFO David R. Wells departs; CEO Lucas becomes interim CFO","bullets":["David R. Wells ceased as CFO effective May 16, 2025, without cause.","Wells entitled to separation benefits per his August 2023 employment agreement.","CEO Brent T. Lucas will serve as interim principal financial officer.","Search for a permanent successor CFO has been initiated."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-045109","json":"https://secwatch.observer/filing/0001213900-25-045109.json","markdown":"https://secwatch.observer/filing/0001213900-25-045109.md","text":"https://secwatch.observer/filing/0001213900-25-045109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/ea0242673-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T02:06:11.651862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cede2fd3ff","claim":"David R. Wells departed as Chief Financial Officer at Envoy Medical, Inc..","evidence_excerpt":"Effective May 16, 2025, David R. Wells ceased serving as Chief Financial Officer of Envoy Medical, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f631140fd1","claim":"Brent T. Lucas was appointed as principal financial officer at Envoy Medical, Inc..","evidence_excerpt":"The Company’s Chief Executive Officer, Brent T. Lucas, will serve as principal financial officer on an interim basis until a successor Chief Financial Officer is appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"principal financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}